Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Russia Clear all

61 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20064
20073
20081
20093
20103
20114
20125
20134
20145
20151
20174
20182
20196
20201
202110

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Active, not recruiting10
Terminated10
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca9
Novartis Pharmaceuticals5
AbbVie3
Pfizer3
Sanofi3
Amgen2
Eli Lilly and Company2
Hoffmann-La Roche2
Achieve Life Sciences1
Alaunos Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis61
Breast Neoplasms16
Neoplasms14
Carcinoma, Non-Small-Cell Lung11
Colorectal Neoplasms4
Prostatic Neoplasms4
Bone Neoplasms3
Breast Diseases3
Carcinoma3
Carcinoma, Renal Cell3

Trials

Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.